Nu-V3 is a patented and trademark registered neuro-modulation device to treat pain, anxiety, depression and sleep-lessness, which is miniature, wearable, non-invasive and non-pharmaceutical.
Nu-Life Solutions is the global developer of the Nu-V3 technology and delivers Nu-V3 through regional providers such as Nu-Life USA, Nu-Life Europe, Nu-Life Japan, Nu-Life Latin America and Nu-Life Canada.
Neuromodulation by Nu-V3
Neuromodulation is technology that acts directly upon nerves. It is the alteration - or modulation - of nerve activity by delivering either electrical or pharmaceutical (drug) agents directly to a target area.
Nu-Life's Nu-V3 technology delivers a micro-electrical signal to create cranial nerve stimulation non-invasively and non-pharma-ceutically directly through the auricular (ear) area, all while allowing the patient to perform almost any everyday activity.
More on neuromodulation
The Top 3 - News and Events
Information contained on this website is intended to educate the viewer about Nu-V3, the Nu-V3 Program, corporate status and plan for market entry 2021. Use of Nu-V3 and Nu-V3 treatment programs are conducted under strict FDA guidelines and are IRB approved. Some areas on this website are confidential and password protected, containing proprietary information and intellectual property of Nu-Life Solutions and Nu-Life Products, Inc, which may not be reproduced or disclosed under any circumstances without the express written permission of Nu-Life Solutions, SEZC.